Relationship between acute radiation pneumonitis and dosimetric factors in intensity-modulated radiotherapy for lung caner:a study based on different lesion locations
Huang Rui,Zhu Xiaodong,Fu Qingguo,Huang Jiangqiong,Yang Liuting,Chen Long
Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China (Zhu XD,Fu QG,Huang JQ,Yang LT,Chen L); Department of Radiation Oncology,Sichuan Cancer Hospital,Chengdu 610041,China (Huang R)
Abstract： Objective To explore the dosimetric factors for acute radiation pneumonitis (ARP) after restricted field intensity-modulated radiotherapy (IMRT) for lung caner based on different lesion locations. Methods A retrospective study of ARP was performed among 113 patients with lung cancer undergoing restricted field IMRT from 2013 to 2015. The Radiation Therapy Oncology Group criteria were used to grade ARP. Comparison was made by χ2 test and independent sample t-test. The logistic regression model was used for multivariate analysis. The receiver operating characteristic curve was used to predict the optimal cut-off value. Results The statistical analysis showed that the incidence of ARP was not related to clinical factors. The V5 of the diseased lung was an independent predictor of the incidence of grade>2 ARP (P=0.016). The optimal cut-off value of V5 was 71.6%. According to the lesion locations in patients, the rV5 was an independent predictor of the incidence rates of ARP in the right lung, upper right lung, and right middle/lower lung (P=0.020, 0.020, 0.049) with optimal cut-off values of 66.2%, 74.7%, and 87.5%, respectively. The aV5 was an independent predictor of the incidence of ARP in mediastinal lung cancer (P=0.009) with an optimal cut-off value of 66.73%. Conclusions The V5 of the diseased lung is an independent predictor of the incidence of grade>2 ARP. In terms of the different lesion locations, the rV5 is an independent predictor of the incidence rates of grade>2 ARP in the right lung, upper right lung, and right middle/lower lung. The aV5 is an independent predictor of the incidence of ARP in mediastinal lung cancer.
Huang Rui,Zhu Xiaodong,Fu Qingguo et al. Relationship between acute radiation pneumonitis and dosimetric factors in intensity-modulated radiotherapy for lung caner:a study based on different lesion locations[J]. Chinese Journal of Radiation Oncology, 2016, 25(12): 1301-1304.
[1] Kong FM,Ten Haken R,Eisbruch A,et al. Non-small cell lung cancer therapy-related pulmonary toxicity:an update on radiation pneumonitis and fibrosis[J].Semin Oncol,2005,32(S3):S42-S54.10.1053/j.seminoncol.2005.03.009. [2] Wang SL,Liao ZX,Wei X,et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J].Int J Radiat Oncol Biol Phys,2006,66(5):1399-1407.10.1016/j.ijrobp.2006.07.1337. [3] 付和谊,卢冰,徐冰清,等.Ⅲ＋Ⅳ期非小细胞肺癌三维适形放疗正常肺 V5、V10预测急性RP前瞻性临床研究[J].中华放射肿瘤学杂志,2009,18(6):439-442.10.3760/cma.j.issn.1004-4221.2009.06.439. Fu HY,Lu B,Xu BQ,et al. Prospective study of lung V5 and V10 in predicting radiation-induced lung injury in advanced non-small-cell lung cancer treated with three-dimensional conformal radiation therapy[J].Chin J Radiat Oncol,2009,18(6):439-442.10.3760/cma.j.issn.1004-4221.2009.06.439. [4] 王静,王平,庞青松,等.非小细胞肺癌三维适形放疗急性RP临床及剂量学因素分析[J].中华放射肿瘤学杂志,2009,18(6):448-451.10.3760/cma.j.issn.1004-4221.2009.06.448. Wang J,Wang P,Pang QS,et al. Clinical and dosimetric factors associated with radiation-induced lung damage in patients with non-small cell lung cancer treated with three-dimentional conformai radiotherapy[J].Chin J Radiat Oncol,2009,18(6):448-451.10.3760/cma.j.issn.1004-4221.2009.06.448. [5] 庄婷婷,柳青,张黎,等.非小细胞肺癌三维适形放疗同期化疗后急性RP发生因素分析[J].中华放射肿瘤学杂志,2009,18(6):443-447.10.3760/cma.j.issn.1004-4221.2009.06.443. Zhuang TT,Liu Q,Zhang L,et al. Risk factors of acute radiation pneumonitis in patients with non-small cell lung cancer after concur-rent three-dimensional conformal radiotherapy and chemotherapy[J].Chin J Radiat Oncol,2009,18(6):443-447.10.3760/cma.j.issn.1004-4221.2009.06.443. [6] Rancati T,Ceresoli GL,Gagliardi G,et al. Factors predicting radiation pneumonitis in lung cancer patients:a retrospective study[J].Radiother Oncol,2003,67(3):275-283.10.1016/S0167-8140(03)00119-1. [7] 王绿化.肺的放射性损伤[M]//殷蔚伯,谷铣之.肿瘤放射治疗学(3版)[M].北京:中国协和医科大学出版社,2002:675.Wang LH.Radiation injury of lung[A]//Yin WB,Gu XZH.Radiation Oncology (3 ed)[M].Beijing:Peking Union Medical College press,2002:675. [8] Claude L,Pérol D,Ginestet C,et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer:clinical and dosimetric factors analysis[J].Radiother Oncol,2004,71(2):175-181.10.1016/j.radonc.2004.02.005. [9] Tsujino K,Hirota S,Endo M,et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[J].Int J Radiat Oncol Biol Phys,2003,55(1):110-115.10.1016/S0360-3016(02)03807-5. [10] Hernando ML,Marks LB,Bentel GC,et al. Radiation-induced pulmonary toxicity:a dose-volume histogram analysis in 201 patients with lung cancer[J].Int J Radiat Oncol Biol Phys,2001,51(3):650-659.10.1016/S0360-3016(01)01685-6.
2016, Vol. 25 
